Why We Do What We Do
Why We Created
Click onto each designated tab for our three reasons.
Catheter-Related Bloodstream Infections (CRBSI/CLABSI) are a serious problem. According to the Centers for Disease Control and Prevention, an estimated 250,000 cases of CLABSI occur in hospitals in the United States each year. An estimated 80,000 CLABSIs occur in intensive care units (ICUs) alone. Up to 1 in 4 patients who contract CLABSI die. Even when not fatal, CLABSIs can develop into other serious conditions, leading to longer, costlier hospital stays.
The usage of ACTIVCap can help reduce CLABSI incidences.
1
3
2
1
American Hospital Association website. https://www.aha.org/case-studies/2016-09-16-successful-team-approach-reduce-central-line-associated-bloodstream. Published September 2016. Accessed April 16, 2025.
2
Centers for Disease Control and Prevention website. https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdf. Published March, 2011. Accessed April 16, 2025.
3
Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81(9): 1159-1171
